{"id":"methadone-tablets","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Constipation"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Methadone tablets are a type of opioid medication that binds to the mu-opioid receptor, which is responsible for pain perception and reward processing in the brain. By activating this receptor, methadone helps to reduce the severity of withdrawal symptoms and alleviate chronic pain.","oneSentence":"Methadone tablets work by activating the mu-opioid receptor in the brain, which helps to reduce withdrawal symptoms and alleviate pain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:22:36.647Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic pain"},{"name":"Opioid use disorder"}]},"trialDetails":[{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT04145674","phase":"PHASE2","title":"A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo","status":"SUSPENDED","sponsor":"Mauro Manconi","startDate":"2022-10-22","conditions":"Restless Legs Syndrome","enrollment":50},{"nctId":"NCT06323824","phase":"PHASE4","title":"Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-06-04","conditions":"Opioid Use Disorder","enrollment":600},{"nctId":"NCT05693675","phase":"PHASE2, PHASE3","title":"Postoperative Oral Methadone After Major Spine Surgery; Safety, Feasibility and Efficacy in Prevention of Progression to Chronic Opioid Usage at 3 Months","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-10-01","conditions":"Spine Surgery","enrollment":""},{"nctId":"NCT06735079","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)","status":"WITHDRAWN","sponsor":"MGGM LLC","startDate":"2024-12-27","conditions":"Major Depressive Disorder (MDD)","enrollment":""},{"nctId":"NCT05161351","phase":"PHASE4","title":"Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2021-07-23","conditions":"Addiction Opiate","enrollment":16},{"nctId":"NCT03365362","phase":"PHASE4","title":"A Trial of Directly Observed and Long-term Varenicline","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-10-25","conditions":"Tobacco Use Disorder, Opioid-use Disorder","enrollment":243},{"nctId":"NCT04480554","phase":"PHASE2","title":"Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2023-01-30","conditions":"Opioid-use Disorder, HIV-1-infection, Immune Activation","enrollment":225},{"nctId":"NCT02929589","phase":"PHASE3","title":"Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy","status":"TERMINATED","sponsor":"Mike O'Callaghan Military Hospital","startDate":"2018-07-05","conditions":"Pain, Hernia","enrollment":18},{"nctId":"NCT05235191","phase":"PHASE3","title":"Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2019-09-06","conditions":"Neuropathic Pain","enrollment":80},{"nctId":"NCT04941443","phase":"PHASE4","title":"Methadone and Medication Abortion","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2021-10-04","conditions":"Pain, Medical Abortion","enrollment":4},{"nctId":"NCT05325164","phase":"PHASE3","title":"Methadone for 'Adenocarcinopathic' Pain Treatment","status":"WITHDRAWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-09","conditions":"Cancer Pain, Adenocarcinoma","enrollment":""},{"nctId":"NCT02363998","phase":"PHASE3","title":"Open-Label, Safety Study of Lofexidine","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2015-02","conditions":"Opioid Withdrawal","enrollment":286},{"nctId":"NCT01733693","phase":"PHASE4","title":"Neurocognitive Effects of Opiate Agonist Treatment","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2013-01","conditions":"Opioid-Related Disorders, HIV, HIV Infections","enrollment":135},{"nctId":"NCT03127358","phase":"NA","title":"Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2017-11-14","conditions":"Hepatitis C, Medication Adherence","enrollment":11},{"nctId":"NCT03033732","phase":"PHASE4","title":"A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse","status":"COMPLETED","sponsor":"Didier Jutras Aswad","startDate":"2017-10-02","conditions":"Opioid Use Disorder","enrollment":272},{"nctId":"NCT01205516","phase":"PHASE4","title":"Methadone in Neuropathic Pain","status":"TERMINATED","sponsor":"Nova Scotia Health Authority","startDate":"2013-01","conditions":"Chronic Neuropathic Pain","enrollment":14},{"nctId":"NCT04112550","phase":"PHASE1","title":"Clinical Effectiveness of Pre-operative Methadone in Single Level Lateral Transpsoas Interbody Fusions","status":"UNKNOWN","sponsor":"The Methodist Hospital Research Institute","startDate":"2020-02-11","conditions":"Degenerative Disc Disease, Spondylolisthesis, Lumbar Region","enrollment":150},{"nctId":"NCT02593396","phase":"PHASE2","title":"Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men","status":"COMPLETED","sponsor":"University of Malaya","startDate":"2015-12","conditions":"Sexual Dysfunctions, Psychological, Hypoactive Sexual Desire Disorder, Erectile Dysfunctions","enrollment":80},{"nctId":"NCT00386243","phase":"NA","title":"Evaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2007-12","conditions":"Low Back Pain, Pain, Pain, Intractable","enrollment":242},{"nctId":"NCT02715700","phase":"PHASE1","title":"Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-09-28","conditions":"Human Immunodeficiency Virus (HIV) Infection","enrollment":14},{"nctId":"NCT00768482","phase":"PHASE3","title":"A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence","status":"TERMINATED","sponsor":"Titan Pharmaceuticals","startDate":"2008-09","conditions":"Opioid Dependence","enrollment":9},{"nctId":"NCT01114308","phase":"PHASE3","title":"A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction","status":"COMPLETED","sponsor":"Titan Pharmaceuticals","startDate":"2010-04","conditions":"Opioid Dependency","enrollment":287},{"nctId":"NCT01911845","phase":"PHASE2","title":"An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or Buprenorphine","status":"COMPLETED","sponsor":"AbbVie","startDate":"2013-04","conditions":"Chronic Hepatitis C Infection, Chronic Hepatitis C","enrollment":38},{"nctId":"NCT01558934","phase":"PHASE1","title":"Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2012-02","conditions":"Opioid Dependence, Methadone Withdrawal Syndrome","enrollment":6},{"nctId":"NCT00577005","phase":"PHASE2","title":"Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients","status":"COMPLETED","sponsor":"Yale University","startDate":"2007-07","conditions":"Cocaine Dependence, Opioid Dependency","enrollment":28},{"nctId":"NCT01650649","phase":"PHASE1","title":"Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients","status":"COMPLETED","sponsor":"USWM, LLC (dba US WorldMeds)","startDate":"2012-07","conditions":"Opioid Dependence, Methadone Withdrawal Syndrome","enrollment":27},{"nctId":"NCT01396005","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-09","conditions":"Hepatitis C Virus","enrollment":21},{"nctId":"NCT02958566","phase":"PHASE4","title":"Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery","status":"UNKNOWN","sponsor":"University of Illinois College of Medicine at Peoria","startDate":"2017-01","conditions":"Colon Cancer, Colon Diverticulosis, Colonic Neoplasms","enrollment":80},{"nctId":"NCT01821430","phase":"PHASE2","title":"Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription Opioids","status":"TERMINATED","sponsor":"Georgetown University","startDate":"2013-03","conditions":"Chronic Pain","enrollment":4},{"nctId":"NCT02391571","phase":"PHASE3","title":"A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects","status":"COMPLETED","sponsor":"Elite Laboratories, Inc","startDate":"2015-02","conditions":"Withdrawal Symptoms","enrollment":26},{"nctId":"NCT01946555","phase":"","title":"Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2013-09","conditions":"Tumor, Cancer Pain, Breakthrough Cancer Pain","enrollment":150},{"nctId":"NCT01580163","phase":"NA","title":"Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification","status":"COMPLETED","sponsor":"Shanghai Mental Health Center","startDate":"2009-09","conditions":"Heroin Addiction","enrollment":554},{"nctId":"NCT01560221","phase":"PHASE1","title":"Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Substance-related Disorders, HIV Risk Behavior","enrollment":38},{"nctId":"NCT02045693","phase":"PHASE1","title":"Drug Interaction & Methadone & Buprenorphine","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2014-02","conditions":"Hepatitis C","enrollment":32},{"nctId":"NCT00879996","phase":"PHASE4","title":"Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2009-04","conditions":"Opiate Addiction","enrollment":54},{"nctId":"NCT00227357","phase":"","title":"The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration","status":"COMPLETED","sponsor":"Ruth M. Rothstein CORE Center","startDate":"2005-07","conditions":"HIV Infections, AIDS, Opiate Dependence","enrollment":101},{"nctId":"NCT00750217","phase":"PHASE4","title":"Transfer From Methadone to Buprenorphine Maintenance Treatment Using Buprenorphine Patches","status":"UNKNOWN","sponsor":"Psychiatric University Hospital, Zurich","startDate":"2008-08","conditions":"Heroin Addiction","enrollment":10}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"HAEMOGLOBIN DECREASED"},{"count":1,"reaction":"ANXIETY"},{"count":1,"reaction":"BLOOD TRIGLYCERIDES INCREASED"},{"count":1,"reaction":"CARDIOMEGALY"},{"count":1,"reaction":"DELIRIUM"},{"count":1,"reaction":"DIABETES MELLITUS"},{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"DRUG TOXICITY"},{"count":1,"reaction":"HEPATOSPLENOMEGALY"},{"count":1,"reaction":"HYPERTENSION"}],"_approvalHistory":[],"publicationCount":28,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mytedom"],"phase":"phase_3","status":"active","brandName":"methadone tablets","genericName":"methadone tablets","companyName":"University of Sao Paulo","companyId":"university-of-sao-paulo","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methadone tablets work by activating the mu-opioid receptor in the brain, which helps to reduce withdrawal symptoms and alleviate pain. Used for Chronic pain, Opioid use disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}